COLARD Eyes SRL
COLARD Eyes reported total assets of 179,357 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of COLARD Eyes shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -27 % Total assets -53 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
COLARD Eyes's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 58,419 € | ||||
| Equity | 154,817 € | ||||
| Cash | 61,259 € | ||||
| EBITDA | 89,519 € | ||||
| Total assets | 179,357 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 19 Aug 2022
COLARD Eyes's financial analysis
- Solvency86.3%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of COLARD Eyes
COLARD Eyes's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0763.686.938
- VAT number
- BE0763686938
- Peppol
- Registered · 0208:0763686938 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Feb 2021
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
COLARD Eyes (SRL) has been based in Uccle since 2021, active in: medical specialists activities. For 2025, it reports a net profit of 58,419 € and equity of 154,817 €; its revenue is not published. Its solvency stands at 86.3%, above the median of its sector (67.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to COLARD Eyes
Companies in the same business, of comparable size and area, outside its group.
- Docteur Sarah Djebara - Medecine Interne Medical specialists activities Uccle · balance sheet 181,309 €
- Médicale PUTZEYS Virginie Medical specialists activities Hannut · balance sheet 179,120 €
- Meulders Medical specialists activities Saint-Georges-sur-Meuse · balance sheet 177,401 €
- Docteurs Hans-Poirrier Medical specialists activities Liège · balance sheet 179,257 €
- DR Anne-Daphne Wibaux, Anesthesie Medical specialists activities Woluwe-Saint-Pierre · balance sheet 179,735 €
- Stellian Carole Medical specialists activities Andenne · balance sheet 179,764 €
- J.P. Berger Medical specialists activities Chaudfontaine · balance sheet 179,843 €
- Dr. Milad Hammal Medical specialists activities Diest · balance sheet 178,840 €
Frequently asked questions about COLARD Eyes
What is the revenue of COLARD Eyes?
COLARD Eyes files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of COLARD Eyes?
In Belgium, the VAT number is the company number prefixed with BE: BE0763686938 for COLARD Eyes, if the company is VAT-registered. Its company number (CBE) is 0763.686.938.
Where is the registered office of COLARD Eyes?
According to the CBE register, the registered office of COLARD Eyes is in 1180 Uccle.
What is the equity of COLARD Eyes?
At the close of the 2025 financial year, the equity of COLARD Eyes amounts to 154,817 €, a solvency of 86.3% of total assets.
Who manages COLARD Eyes?
The register lists 1 active mandates at COLARD Eyes. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of COLARD Eyes
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →